Chinese CROs to Adopt OmniComm TrialOne Solution

Article

OmniComm Systems announces the signing of contracts to provide the company’s TrialOne clinical automation solution to three clinical research organizations in China.

OmniComm Systems announces the signing of contracts to provide the company’s TrialOne clinical automation solution to three clinical research organizations in China. The agreements for TrialOne were made with Xiyuan Hospital, the Chinese Anti-Cancer Association (CACA) and eStart Medical Technology Co., Ltd.

Read the full release here

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.